HealthCor Management’s Avantor AVTR Stock Holding History

HealthCor Management’s Portfolio AVTR Stock Details AVTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-428,380	Closed	-$18.1M	–	65
2021 Q4	$18.1M	Buy	+428,380	New	+$16.9M	0.98%	32

Other funds holding AVTR

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

NMVA

New Mountain Vantage Advisers New York $4.33B AUM 35.3% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

HealthCor Management's AVTR Position: Q1 2022 in Review

HealthCor Management sold out of Avantor (AVTR) in Q1 2022, closing a stake of 428,380 shares — an estimated $18.1M sold.

HealthCor Management first reported a position in AVTR in Q4 2021 and held it in 1 quarter. The position peaked at $18.1M in Q4 2021. 482 funds tracked by Wall St. Rank hold AVTR as of Q1 2022.

HealthCor Management reported no remaining Avantor position as of Q1 2022 after selling out during the quarter.
HealthCor Management sold 428,380 Avantor shares in Q1 2022, an estimated $18.1M.
HealthCor Management first reported a position in Avantor in Q4 2021 and held it in 1 quarter.
HealthCor Management's Avantor position peaked at $18.1M in Q4 2021.
482 funds tracked by Wall St. Rank held Avantor as of Q1 2022.

Based on HealthCor Management's 13F filing for Q1 2022, filed 16 May 2022.